Bristol-Myers Squibb Company (BMY) Q1 2014 Earnings Results

Bristol-Myers Squibb Beats on EPS, Stock Down 2.07%

Bristol-Myers Squibb reported an EPS of $0.46, exceeding expectations by 4.31%. However, the stock dropped by 2.07% in reaction to the earnings report. The lack of revenue data and management commentary may have contributed to investor uncertainty.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.46	N/A	+4.31%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record, and the analysis is based solely on numerical results.

Bristol-Myers Squibb Beats on EPS, Stock Down 2.07%

Key numbers

Management commentary

Bristol-Myers Squibb Company

More earnings this week

Bristol-Myers Squibb Beats on EPS, Stock Down 2.07%

Key numbers

Management commentary